Inovio Pharmaceuticals misses by $0.04, beats on revenues

Inovio Pharmaceuticals (INO): Q4 EPS of -$0.07 misses by $0.04.

Revenue of $1.7M beats by $0.34M.

From other sites
Comments (2)
  • Kaiserdog76
    , contributor
    Comments (166) | Send Message
    Excellent cash management. Visibility out to 2017. Flu data forth coming.
    17 Mar 2014, 06:35 AM Reply Like
  • moves
    , contributor
    Comments (23) | Send Message
    Inovio Pharmaceuticals ($INO) Recognized with "Best Therapeutic Vaccine" Award at World Vaccine Congress 2014
    26 Mar 2014, 07:49 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs